iHuman annual stock-based compensation
2020
2021
2022
2023
2024
2025
iHuman Stock-Based Compensation Growth & History (IH)
iHuman's stock-based compensation was $103,000 for fiscal 2025.
View full iHuman company overviewiHuman annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $103,000 | −$284,000 | −73.39% |
| 2024 | 2024-12-31 | $387,000 | −$942,000 | −70.88% |
| 2023 | 2023-12-31 | $1.3M | −$562,000 | −29.72% |
| 2022 | 2022-12-31 | $1.9M | −$490,000 | −20.58% |
| 2021 | 2021-12-31 | $2.4M | −$9.9M | −80.55% |
| 2020 | 2020-12-31 | $12.2M | — | — |
iHuman stock-based compensation trends
Over the last five fiscal years, iHuman's stock-based compensation decreased from $12.2M to $103,000, a change of −$12.1M.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review iHuman source filings ↗